25773-35-7

Basic information

• Product Name: (tyr(so3H)27)-cholecystokinin fragment*26-29 amid
• CAS NO: 25773-35-7
• Molecular Formula: C₂₀H₂₉N₅O₁₀S₂
• Molecular Weight: 563.59
• Mol File: 25773-35-7.mol
• Article Data: 0

Chemical Properties

• CAS DataBase Reference: (tyr(so3H)27)-cholecystokinin fragment*26-29 amid(CAS DataBase Reference)
• NIST Chemistry Reference: (tyr(so3H)27)-cholecystokinin fragment*26-29 amid(25773-35-7)
• EPA Substance Registry System: (tyr(so3H)27)-cholecystokinin fragment*26-29 amid(25773-35-7)

Safety Data

• Hazardous Substances Data: 25773-35-7(Hazardous Substances Data)

Usage

Description

(Tyr(SO3H)27)-cholecystokinin fragment26-29 amid is a synthetic peptide derived from the hormone cholecystokinin (CCK), which is involved in the regulation of digestion and appetite. This specific fragment is composed of 4 amino acids and a modified tyrosine residue with a sulfonic acid group, amidated at the C-terminus. The modification of the tyrosine residue aims to replicate the active form of CCK, making it a valuable tool for research purposes.

Uses

Used in Pharmaceutical Research:
(Tyr(SO3H)27)-cholecystokinin fragment26-29 amid is used as a research compound for studying the physiological effects and signaling pathways of CCK, particularly focusing on satiety and appetite regulation. Its role in understanding the mechanisms behind appetite control can potentially lead to the development of new treatments for obesity and related metabolic disorders.
Used in Digestive Health Applications:
In the field of digestive health, (Tyr(SO3H)27)-cholecystokinin fragment26-29 amid is used as a therapeutic agent to modulate the release of digestive enzymes and influence gut motility. This can help in the treatment of various gastrointestinal disorders, such as irritable bowel syndrome (IBS) and gastroesophageal reflux disease (GERD), by improving digestion and reducing symptoms.
Used in Nutritional Science:
(Tyr(SO3H)27)-cholecystokinin fragment26-29 amid is used as a research tool in nutritional science to investigate the role of CCK in appetite control and energy balance. This knowledge can contribute to the development of novel strategies for weight management and the formulation of effective dietary interventions for obesity and other weight-related health issues.
Used in Neuropeptide Research:
In the field of neuropeptide research, (Tyr(SO3H)27)-cholecystokinin fragment26-29 amid is used as a model compound to study the structure-function relationships of CCK and its analogs. This can provide insights into the design of new neuropeptide-based drugs with potential applications in various therapeutic areas, including pain management, anxiety, and depression.